OGEN News and Press, Oragenics Inc. From 06/05/23

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases, announces the award of a grant from CQDM, a Canadian bioresearch consortium, for the collaborative development of a variant-agnost...

2023-03-31 15:00:41 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces that Kim Murphy, Chief Executive Officer, will be participating in the World Vaccine Congress Washing...

Potentially Addresses Life-Threatening Antibiotic-Resistant Infections Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases, today reports favorable findings from third par...

2023-03-08 09:20:28 ET Oragenics ( NYSE: OGEN ) appointed seasoned financial executive Janet Huffman as CFO, effective Mar.7, 2023. Most recently, Ms. Huffman served as CFO for TRxADE HEALTH. For further details see: Oragenics names industry v...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces the appointment of Janet Huffman as Chief Financial Officer, effective March 7, 2023. Ms. Huffman is ...

Oragenics ( NYSE: OGEN ) shares rise 14% after the company entered into an exclusive global license agreement with Inspirevax for its novel intranasal mucosal adjuvant, BDX301, for the development of NT-CoV2-1, Oragenics’ lead intranasal COVID-19 vaccine candidate. Unde...

Licensing milestones provides opportunity to expand vaccine program Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including COVID-19, today announced that the Company ha...

Oragenics ( NYSE: OGEN ) said NYSE has notified the biotech company about having regained compliance with the stock exchange's continued listing standards. The Feb. 1 notice indicated that the company has resolved the continued listing deficiency with respect to its low selling p...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including COVID-19, today announced that the Company has received formal notice from the NYSE American, LLC (“NYSE American”...